Expert Speaker Panel
Speakers for San Diego 2027
Santosh A. Misal
Staff Scientist/ Manager Mass Spectrometry Facility
National Institute of Allergy and Infectious Diseases (NIAID)
LinkedinAccelerating Precision Immuno-Oncology Through Biomarker-Driven Innovation, now on the West Coast.
San Diego, USA. One of the world's most concentrated biotech and genomics corridors, anchored by La Jolla and Torrey Pines.
10–11 February 2027. Two full conference days.
Two parallel streams, networking lunches, and a Drinks Reception on Day 1.
anandhu@convolign.com
+1-617-604-3359
ImmunoMark Summit West Coast Edition is a flagship, two-day scientific and industry-focused conference, bringing together senior leaders, researchers, and decision-makers from biopharma, biotechnology, diagnostics, academia, and the wider life sciences ecosystem. The conference is a dedicated platform to explore the latest scientific advances, translational strategies, and clinical insights shaping immuno-oncology and biomarker-driven precision medicine.
Hosted in San Diego, one of the world's leading centres for biotech innovation, genomics, and translational oncology research, this Launch Edition brings the ImmunoMark Summit series to the West Coast for the first time. The programme is curated to reflect current industry priorities, addressing how cutting-edge science is translated into clinically meaningful therapies, supported by robust biomarker strategies and advanced diagnostic approaches.
Two fully independent parallel tracks give attendees the flexibility to go deep on their core area of expertise while still gaining a broader view of the IO and biomarker landscape.
From CAR-T to NK cell and TCR-T platforms, explore the modalities pushing immuno-oncology beyond current standard of care.
How AI and machine learning are reshaping target identification, biomarker discovery, and patient stratification at scale.
Single-cell sequencing, spatial biology, and digital pathology, brought together to inform clinical decision-making.
Advances in ctDNA and non-invasive biomarker platforms enabling real-time, dynamic treatment monitoring.
Co-development strategies, regulatory pathways, and the economics of bringing CDx solutions to market.
Bispecifics, ADCs, and combination approaches designed to outpace resistance mechanisms in checkpoint therapy.
The latest data, platform innovations, and pipeline insights from world-leading IO and biomarker researchers.
Network with 300+ senior decision-makers through structured 1:1 meetings, panels, and a Day 1 Drinks Reception.
San Diego joins a series that has featured leaders from AstraZeneca, Roche, Merck, J&J, Novartis, and GSK across Boston and London.
An agenda built by the scientific community to reflect genuine industry priorities, not vendor agendas.
CEOs, CSOs, VPs of Translational Medicine, Oncology R&D Directors, and BD Executives optimizing pipelines through precision medicine.
Biomarker discovery and validation scientists, CDx developers, and bioinformatics leads accelerating discovery to clinical utility.
Oncologists, clinical trial investigators, and translational medicine leads integrating biomarker strategies into trial design.
Principal investigators, group leaders, and regulatory affairs professionals tracking biomarker qualification and approval pathways.
Sector breakdown and the seniority figure below are two separate, independent measures, not parts of the same total.
of attendees hold VP-level seniority or above, consistent across the ImmunoMark Summit portfolio.
The immuno-oncology and biomarker landscape is one of the fastest-growing sectors in global life sciences. The data below illustrates the scale of the opportunity, and why ImmunoMark Summit sits at its centre.
Sources: Grand View Research; MarketsandMarkets; IQVIA Institute; FDA. Figures are industry estimates current as of 2025–2026 and vary by methodology, recheck before publishing.
Staff Scientist/ Manager Mass Spectrometry Facility
National Institute of Allergy and Infectious Diseases (NIAID)
LinkedinA high-intensity two-day programme spanning the full spectrum of immuno-oncology and biomarker science. Both streams run simultaneously, with shared networking breaks and a Drinks Reception at the end of Day 1.
| Time | Stream 1: Immuno-Oncology | Stream 2: Biomarkers & CDx |
|---|---|---|
| 08:00 | Registration & Networking Breakfast | |
| 08:55 | Chairperson Opening Remarks | |
| 09:00 | Keynote: The Future of Precision Immunotherapy on the West Coast | Keynote: Biomarkers as the Foundation of Precision Oncology |
| 09:30 | Next-Generation Cell Therapies Beyond CAR-T | Spatial Biology and Digital Pathology for Clinical Decision-Making |
| 10:00 | Engineering the Tumor Microenvironment for Durable Responses | Liquid Biopsy & MRD Monitoring Across Solid Tumors |
| 10:30 | Morning Coffee Break | |
| 11:00 | AI-Driven Discovery of Immuno-Oncology Targets | Multi-Omics Biomarker Strategies in Drug Development |
| 11:30 | Bispecific and Multispecific Immune Engagers | Single-Cell Sequencing Applications in Oncology |
| 12:00 | Cancer Vaccines and Personalized Neoantigen Platforms | AI-Powered Biomarker Discovery and Validation |
| 12:30 | Industry Case Study / Sponsor Slot | Industry Case Study / Sponsor Slot |
| Time | Stream 1: Immuno-Oncology | Stream 2: Biomarkers & CDx |
|---|
End of Day 1 from 18:00. Informal, relationship-first networking to close out the day.
Structured matchmaking with sponsors, speakers, and delegates.
Shared lunches both days, built for cross-community connection.
Dedicated exhibition space running across both conference days.
Sponsoring ImmunoMark Summit West Coast Edition 2027 places your brand at the centre of the immuno-oncology and biomarker transformation taking shape in San Diego and across the West Coast market. You gain direct access to 300+ senior decision-makers.
Unlike generic life sciences conferences, ImmunoMark is a curated, senior-audience platform engineered for deep engagement, strategic dialogue, and long-term partnerships.
Reserved branded speaking slot (Platinum & Gold tiers)
Dedicated stand for demos and direct delegate engagement
Post-event access for structured follow-up outreach
Structured meetings with your most relevant prospects
Logo across website, agenda, email, social, and on-site materials
Pre and post-event coverage across ImmunoMark channels
San Diego will be ImmunoMark Summit's debut on the West Coast. Here's a look at the calibre and energy of our Boston and London editions, which have each brought together 300+ senior life sciences professionals for two days of scientific exchange and strategic networking.
"We really liked the focus of the event, the topics, the talks. It's a really good opportunity to engage with people, and the support we get is great. Based on our experience, we'd be very interested in sponsoring the next annual event."
"We're always interested in sponsoring an interesting conference. Based on this year's experience, I expect we'll manage to get budget for the next edition."
"The conversations have been very high level, the footfall has been great, and the research happening around the event is genuinely life changing. We'll be very interested in sponsoring again."
Full venue details will be shared with registered delegates and confirmed sponsors. San Diego is home to a world-leading concentration of biotech, genomics, and immuno-oncology innovation, an ideal setting for ImmunoMark Summit's first West Coast Edition.
Our team is ready to assist.
anandhu@convolign.com +1-617-604-3359 www.immunomarksummit.com300+ senior leaders. Two streams. One agenda: advancing precision oncology on the West Coast.
Register for San Diego Edition300+ senior leaders. Two streams. One agenda: advancing precision oncology.
Waitlist for Boston Edition